Reuter U, Goadsby PJ, Lanteri-Mine M. Efficacy and safety of Erenumab in episodic migraine patients with 2 - 4 prior preventive treatment failures : results from the phase 3b LIBERTY study . EAN 2018, abstract O427.
Fase III-studies naar gantenerumab bij vroege ziekte van Alzheimer
mrt 2024 | Dementie